SHH · 688319.SS
Chengdu Olymvax Biopharmaceuticals Inc.
CN¥26.28+CN¥0.87 (+3.42%)
Chengdu Olymvax Biopharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.47% below the high.
Loading market information…
SHH · 688513.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Chengdu Easton Biopharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.99% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Chengdu Easton Biopharmaceuticals Co., Ltd.’s forward annual dividend is CN¥0.49 per share, paid annual. The forward yield is 1.19% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Chengdu Easton Biopharmaceuticals Co., Ltd.’s next earnings report is currently expected on Apr 29, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Chengdu Easton Biopharmaceuticals Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Chengdu Easton Biopharmaceuticals Co., Ltd. is a pharmaceutical enterprise dedicated to the full spectrum of drug development, encompassing research, development, production, and market distribution of medicinal products. The company offers finished medications tailored for various medical disciplines, including pain management (anesthetics/analgesics), cardiovascular health, oncology, and pediatrics. Beyond ready-to-use drugs, it also manufactures active pharmaceutical ingredients (APIs) for a broader range of therapeutic areas, such as cancer treatment, heart conditions, pain relief, anti-inflammatory uses, gastrointestinal issues, antiemetics, neurological and psychiatric disorders, and urinary system ailments. Established in 2009, the firm is headquartered in Chengdu, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:56 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2024 | Feb 27, 2025 | CN¥0.12 | CN¥309.82M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥26.28+CN¥0.87 (+3.42%)
Chengdu Olymvax Biopharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.47% below the high.
CN¥4.93-CN¥0.12 (-2.38%)
Chengzhi Shareholding Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.59% below the high.
CN¥12.00CN¥0.00 (0.0%)
Zhejiang Jolly Pharmaceutical Co.,LTD’s quoted price sits in the lower half of its reported 52-week range, 35.66% below the high.
CN¥18.26+CN¥0.11 (+0.61%)
Aurisco Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.68% below the high.
CN¥13.63-CN¥0.24 (-1.73%)
China Resources Boya Bio-pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 46.84% below the high.
CN¥4.07-CN¥0.02 (-0.49%)
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong’s quoted price sits in the lower half of its reported 52-week range, 50.73% below the high.
CN¥47.84+CN¥0.18 (+0.38%)
Chengdu Kanghua Biological Products Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.69% below the high.
CN¥28.76-CN¥0.24 (-0.83%)
Shanghai Haohai Biological Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.61% below the high.
